Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc. (TMO)
Compare

TMO Cash Flow Statement

Operating, investing, and financing cash flow analysis

TMO Quarterly Cash Flow Statement (USD)

Quarterly ReportTTM
03/28/2026
12/31/2025
09/27/2025
06/28/2025
03/29/2025
12/31/2024
09/28/2024
06/29/2024
Cash from Operations (CFO)
8.287B1.192B3.457B2.239B1.399B723.000M3.290B2.166B1.960B
6.859B1.651B1.975B1.616B1.617B1.507B1.830B1.630B1.548B
Depreciation & Amortization
2.505B430.000M727.000M663.000M685.000M705.000M742.000M740.000M790.000M
0.000.000.000.000.000.000.0068.000M84.000M
Change in Accounts Receivable
38.716B9.204B10.566B8.911B10.035B9.821B9.626B8.255B7.943B
Change in Inventory
Change in Accounts Payable
Change in Working Capital
760.000M-1.112B447.000M2.151B-726.000M-1.425B594.000M30.000M-216.000M
Cash from Investing
-1.539B-376.000M-465.000M-404.000M-294.000M-362.000M-480.000M-272.000M-301.000M
-12.909B-8.872B0.00-4.037B0.000.000.00-3.112B16.000M
Cash from Financing
Debt Repayment
-4.000B-3.000B-3.000B2.000B0.00-2.000B-1.000B0.000.00
-649.000M-162.000M-162.000M-163.000M-162.000M-149.000M-149.000M-150.000M-149.000M
6.748B816.000M2.992B1.835B1.105B361.000M2.810B1.894B1.659B
Net Change in Cash
-892.000M-6.599B7.868B-2.592B431.000M131.000M-630.000M-2.427B1.578B

TMO Annual Cash Flow Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Cash from Operations (CFO)
7.818B8.667B8.406B9.154B9.543B8.289B4.973B4.543B
6.737B6.335B5.995B6.950B7.725B6.375B3.696B2.938B
Depreciation & Amortization
2.780B3.108B3.406B3.381B2.592B2.325B2.277B2.266B
0.00301.000M278.000M307.000M230.000M196.000M181.000M181.000M
Change in Accounts Receivable
10.566B9.626B8.221B8.115B7.977B5.741B4.349B4.136B
Change in Inventory
Change in Accounts Payable
Change in Working Capital
-1.808B-334.000M-537.000M-1.049B-1.558B-395.000M-619.000M-530.000M
Cash from Investing
-1.525B-1.400B-1.479B-2.243B-2.523B-1.474B-926.000M-758.000M
-4.037B-3.132B-3.660B-39.000M-19.395B-38.000M-715.000M-536.000M
Cash from Financing
Debt Repayment
-3.000B-4.000B-3.000B-3.000B-2.000B-1.500B-1.500B-500.000M
-636.000M-583.000M-523.000M-455.000M-395.000M-337.000M-297.000M-266.000M
6.293B7.267B6.927B6.911B7.020B6.815B4.047B3.785B
Net Change in Cash
5.839B-4.057B-440.000M4.046B-5.845B7.914B305.000M756.000M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Waltham, MA
125,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Marc N. Casper